These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical experiences with methyprylon, a nonbarbiturate sedative and hypnotic drug. BILLOW BW; STEINBERG M; LUPINI SB; ROTHMAN H; CAREY R; PALEY SS; MARTORELLA FJ Int Rec Med; 1960 May; 173():288-92. PubMed ID: 13800724 [No Abstract] [Full Text] [Related]
5. A new, mild sedative-hypnotic, a piperidine derivative (noludar). BRANDMAN O; CONIARIS J; KELLER HE J Med Soc N J; 1955 May; 52(5):246-53. PubMed ID: 14368200 [No Abstract] [Full Text] [Related]
6. Effects of methyprylon (noludar) and phenobarbital on the electrocardiogram. SCHAFFER AI; SEEGERS W J Am Geriatr Soc; 1956 Nov; 4(11):1078-9. PubMed ID: 13376291 [No Abstract] [Full Text] [Related]
7. A study of hypnotic drugs in patients with chronic diseases; comparative efficacy of placebo; methyprylon (noludar) meprobmate (miltown, equanil) pentobarbial; phenobarbital; secobarbital. LASAGNA L J Chronic Dis; 1956 Feb; 3(2):122-33. PubMed ID: 13295345 [No Abstract] [Full Text] [Related]
8. Methyprylon, a new sedative and hypnotic drug. CASS LJ; FREDERIK WS; ANDOSCA JB N Engl J Med; 1955 Oct; 253(14):586-91. PubMed ID: 13266000 [No Abstract] [Full Text] [Related]
9. [Experiences with a barbiturate-free hypnotic and sedative in small children. Clinical and electroencephalographic research on 2,4-dioxo-3,3-diethyl-5-methylpiperidine (Noludar)]. HORSTMANN W Munch Med Wochenschr; 1962 Mar; 104():603-8. PubMed ID: 14449058 [No Abstract] [Full Text] [Related]
10. [Noludar, a new sedative]. LANGE HJ Med Klin; 1956 Feb; 51(8):303-4. PubMed ID: 13308742 [No Abstract] [Full Text] [Related]
11. [ON METHYPRYLON ADDICTION; A CONTRIBUTION OF HYPNOTIC ADDICTION]. NEUMANN H; JANSSEN D Med Klin; 1964 Nov; 59():1829-31. PubMed ID: 14330836 [No Abstract] [Full Text] [Related]
12. The use of a non-barbiturate hypnotic, methyprylone ("noludar") in general practice. BELL JD J Ir Med Assoc; 1959 Sep; 45():82-3. PubMed ID: 13798503 [No Abstract] [Full Text] [Related]
13. Clinical and statistical evaluation of six hypnotic agents. le RICHE W; van BELLE Can Med Assoc J; 1963 Apr; 88(16):837-41. PubMed ID: 13982136 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of methyprylon in chronic insomniac patients with various physical disorders. BILLOW BW; WHITEMAN N; CAREY R; CABODEVILLA A; BARNES L; ROTHMAN N; PALEY SS J Natl Med Assoc; 1962 Mar; 54(2):248-50. PubMed ID: 13869209 [No Abstract] [Full Text] [Related]
15. The use of noludar in pediatric electroencephalography. WINFIELD DL; HUGHES JG Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):713-5. PubMed ID: 13480244 [No Abstract] [Full Text] [Related]
16. Clinical trial with methyprylon in patients with chronic insomnia. REISER P; KAY LL; PRINTZ S; CHERICO P; HARRIS SB Clin Med (Northfield); 1963 Feb; 70():395-9. PubMed ID: 15445956 [No Abstract] [Full Text] [Related]
17. Addiction to "Noludar"; a report of two cases. JENSEN GR N Z Med J; 1960 Sep; 59():431-2. PubMed ID: 13789900 [No Abstract] [Full Text] [Related]
18. Metabolism of methyprylon. RANDALL LO; ILIEV V; BRANDMAN O Arch Int Pharmacodyn Ther; 1956 Jun; 106(4):388-94. PubMed ID: 13341134 [No Abstract] [Full Text] [Related]
19. METHYPRYLON. J Am Med Assoc; 1956 Aug; 161(14):1384. PubMed ID: 13331806 [No Abstract] [Full Text] [Related]
20. Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients. Lomen P; Linet OI J Int Med Res; 1976; 4(1):55-8. PubMed ID: 16792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]